stella
beta
An Exploratory Study of Individualized Neo-antigen mRNA Cancer Vaccine InnoPCV in Advanced Solid Tumor Treatment — Stella
Recruiting
Back to Advanced Solid Tumor trials
Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.
Trial locations
(1 site)
China
The Affiliated Hospital of Guizhou Medical University, Guiyang, China/Guizhou
View full record on ClinicalTrials.gov